Keywords: CGL; congenital general lipodystrophy; Ldlr; low-density-lipoprotein receptor; apoE; apolipoprotein E; FPLC; fast protein liquid chromatography; WAT; white adipose tissue; BAT; brown adipose tissue; VLDL; very-low-density lipoprotein; IDL; intermediate-de
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ACC; acetyl-CoA carboxylase; ADPH; adipophilin; Akt/PKB; protein kinase B; ALOX5; arachidonate 5-lipoxygenase; BTN1A1; butyrophilin subfamily 1 member a1; CIDEA; cell death-inducing DNA fragmentation factor α-like effector A; COX2; cyclooxygenase 2; DGAT
Keywords: NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; FC; free cholesterol; VLDL; very low density lipoprotein; LDL; low density lipoprotein; mTOR; mechanistic target of rapamycin signaling; AMPK; AMP-activated protein kinase; TG; t
Keywords: Familial hypercholesterolemia; FH; Universal screening; Cascade screening; Children; Cholesterol; Hypercholesterolemia; Next-generation sequencing; Genotype; LDLR; APOB; PCSK9;
Keywords: HMG-CoA R; 3-hydroxy-3-methylglutaryl-coenzyme A reductase; 3α-diol; 5alpha-androstane-3alpha,17beta-diol; 3β-diol; 5alpha-androstane-3beta,17beta-diol; 7α-OH; 7α-hydroxycholesterol; 7β-OH; 7β-hydroxycholesterol; 7-keto; 7-ketocholesterol; 24(S)-OH;
Keywords: Estrogen; Insulin resistance; Cholesterol/metabolism; Sex differences; Reverse cholesterol transport; ERα; estrogen receptor alpha; LKO-ERα; deletion of hepatocyte estrogen receptor alpha; CHD; coronary heart disease; SR-BI; scavenger receptor class B m
Keywords: 27-HC; 27-hydroxycholesterol; ER; estrogen receptor; CYP27A1; cytochrome P450, family 27, subfamily A, polypeptide 1; LXR; liver X receptor; BRCA1 and BRCA2; Breast cancer 1 and 2; LDL; low density lipoprotein; HDL; high density lipoprotein; ApoE; apolipo
Keywords: AJ; adherent junction; ApoA1; apoprotein-A1; Apo-B; apoprotein-B; BBB; blood-brain barrier; Chol; Cholesterol; CI; confidence interval; DM; diabetes mellitus; DWM; deep white matter; HbA1C; glycated haemoglobin; tHcy; total homocyeteine; HDL; high density
Keywords: Rare disease; Sterol; Homeostasis; Sterol regulatory element binding protein-2; ABCG8; ATP-binding cassette sub-family G member 8; SREBP-2; Sterol regulatory element-binding protein 2; LDL; low-density lipoprotein; HMGCR; 3-Hydroxy-3-Methylglutaryl-CoA re
Keywords: ABC; ATP-binding cassette; ABCA; ABC subfamily A; AD; Alzheimer's disease; ApoE; apolipoprotein E; APP; amyloid precursor protein; Aβ; amyloid-β; BBB; blood-brain barrier; DAMPs; damage-associated molecular patterns; HDL; high-density lipoprotein; HFD
Keywords: ANCHOR; Effect of AMR101 (Icosapent Ethyl) on Triglyceride Levels in Patients on Statins With High Triglyceride Levels (â¥200 and <500â¯mg/dL); Apo; apolipoprotein; ASAP; Antioxidant Supplementation in Atherosclerosis Prevention; CANTOS; Canakinumab Ant
Keywords: Alirocumab; Hypercholesterolemia; LDLR; APOB; LDLRAP1;
Keywords: ACSVL3; acyl-coA synthetase VL3; ALDH1; aldehyde dehydrogenase; ALDOA; aldolase A; ALDOC; aldolase C; AMPK; 5â² AMP-activated protein kinase; ASNS; asparagine synthetase; BTICs; brain tumor initiating cells; 3-BrOP; 3-bromo-2-oxopropionate-1-propyl ester
Keywords: Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: AMPK; AMP-activated protein kinase; BARCIST; Brown Adipose Reporting Criteria in Imaging Studies; BAT; Brown adipose tissue; BMI; Body mass index; β1-AR; β1-adrenergic receptor; β3-AR; β3-adrenergic receptor; CIT; Cold-induced thermogenesis; CO2; diox
Keywords: ACC; acetyl CoA carboxylase; ACYL; ATP citrate lyase; Akt2; rac-β-serine-threonine kinase; ALA; α-linolenic acid; ALT; alanine aminotransferase; ARA; arachidonic acid, 20:4,Ï6; AST; aspartate aminotransferase; ATGL; adipocyte triglyceride lipase; CD36;
Keywords: Ach; acetylcholine; AChE; cholinesterase; AD; Alzheimer disease; AMT; adsorptive mediated transcytosis; APP; amyloid precursor protein; ARND; age related neurodegenerative disorders; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; CMT; carri
Keywords: ACC; Acetyl-CoA carboxylase; ADPN; adiponectin; AL; Alentejano; BW; body weight; C; commercial; CB; C diet supplemented with betaine; FA; fatty acid; FASN; Fatty acid synthase; H-FABP; Heart-type fatty acid binding protein; HMGCR; 3-Hydroxy-3-methyl-gluta
Keywords: Familial hypercholesterolemia; LDLR; APOB; PCSK9 gene mutations; Genotype-phenotype correlation; Mutation clusters;
Keywords: Atherosclerosis; Brown adipose tissue; Hypercholesterolemia; Cholesterol metabolism; Lipid and lipoprotein metabolism; ApoE; apolipoprotein E; β3-AR; β3-adrenergic receptor; (i)BAT; (interscapular) brown adipose tissue; (T)C; (total) cholesterol; CETP;
Keywords: AKT/PKB; protein kinase B; APPL1; adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; EEA1; early endosomal antigen 1; EGF; epidermal growth factor;; G6Pase; glucose-6-phosphatase;; LDL; low-density lipoprotein;; LDLR;
Keywords: ALA; 5-aminolevulinic acid; AMT; Adsorptive-mediated transcytosis; BBB; Blood-brain barrier; B-CSF; Blood-cerebrospinal fluid barrier; CNS; Central nervous system; CSF; Cerebrospinal fluid; CYPs; Cytochromes P450; FUS; Focused ultrasound; GLUT-1; Glucose
Keywords: Familial hypercholesterolemia; Mutation spectrum; LDLR; APOB; PCSK9;
Keywords: Hypercholesterolemia; Genetics; Cardiovascular; PCSK9; Clinical trial; LDLR; APOB;
Keywords: Aronia; Former smokers; Cholesterol; Inflammation; Oxidative stress; Anthocyanins; Clinical trial; BMI; body mass index; CAT; catalase; CRP; C-reactive protein; CVD; cardiovascular disease; GPX; glutathione peroxidase; HDL-C; high-density lipoprotein chol
Keywords: ACC; acetyl-CoA carboxylase; ApoB; apolipoprotein B; ApoCII; apolipoprotein C-II; APPL-1; adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and a leucine zipper motif; CD36; fatty acid translocase; CETP; cholesteryl est
Keywords: SCFAs; short-chain fatty acids; LDLR; low-density lipoprotein receptor; InsR; insulin receptor; AMPK; AMP-activated protein kinase; PCSK9; proprotein convertase subtilisin kexin 9; PTP1B; protein tyrosine phosphatase 1B; BBR; berberine; TC; total choleste
Keywords: 11KT; 11-ketotestosterone; 17bhsd; 17β-hydroxysteroid dehydrogenase; 17P; 17α-hydroxyprogesterone; 17,20bP; 17,20β-dihydroxy-4-pregnen-3-one; 20b-HSD; 20β-hydroxysteroid dehydrogenase; 20βS; 17,20β,21-trihydroxy-4-pregnen-3-one; actRIIB; activin rec
Keywords: Familial hypercholesterolemia; Clinical criteria; Coronary artery disease; LDLR; APOB;
Keywords: Antiphospholipid antibody; Pregnancy; Placenta; Extravillous trophoblast; aPLs; Antiphospholipid antibodies; APS; Antiphospholipid antibody syndrome; LDLR; Low-density lipoprotein receptor; RAP; Receptor associated protein; TLR4; Toll-like receptor 4;
Keywords: Familial hypercholesterolemia; LDL-receptor mutations; Statins; Hepatocyte transplantation; Liver transplantation; Proprotein convertase subtilisin-like kexin type 9; FH; familial hypercholesterolemia; HoFH; homozygous familial hypercholesterolemia; LDLR;
Keywords: APOB; Familial hypercholesterolemia; Genetics; Greek; LDLR; Mutations; PCSK9;
Keywords: coronary artery disease; gene sequencing; genetics; low-density lipoprotein cholesterol; APOB; apolipoprotein B; CAD; coronary artery disease; CI; confidence interval; FH; familial hypercholesterolemia; LDL; low-density lipoprotein; LDLR; low-density lipo
Keywords: Cardioprotection; Gamma-oryzanol rich fractions-palm oil blend nanoemulsion; Lipid parameter; F2-isoprostane; Heart weight; Hepatic cholesterol metabolism; ABCA; ATP-binding cassette; BF3; boron trifluoride; CVD; cardiovascular disease; EORY; gamma-oryz
Keywords: BAL; bronchoalveolar lavage; LDL; low-density lipoprotein; SMC; smooth muscle cell; TNF-; tumor necrosis factor-; LDLr; LDL receptor; Apoe; apolipoprotein E; OVA; ovalbumin; IMT; intima-media thickness; SMCs; smooth muscle cells; CI; confidence interval;
Keywords: ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; CVD; cardiovascular disease; CYP; cytochrome; EAS; European Atherosclerosis Society; FDA; Food and Drug Administration; FH; Familial hypercholesterolemia; GOF; gain of function; H
Keywords: ACAT; Acyl-coenzyme A: Cholesterol Acetyltransferase; AGPAT2; 1-acylglycerol-3-phosphate-O-acyltransferase-2; AsD; Atherogenic diet; BMT; Bone marrow transplant; CGL; Congenital generalized lipodystrophy; IDL; Intermediate-density lipoprotein; LDLR; Low-d
Keywords: APEX; arrayed primer extension; apoB-100; apolipoprotein B-100; apoE; apolipoprotein E; CETP; cholesteryl ester transfer protein; CVDs; cardiovascular diseases; DGGE; denaturing gradient gel electrophoresis; DHPLC; denaturing high performance liquid chrom
Keywords: DHA; docosahexaenoic acid; AD; Alzheimer׳s disease; ApoE; apolipoprotein E; CNS; central nervous system; LDLR; low-density lipoprotein receptor; VLDLR; very low-density lipoprotein receptor; LRPs; LDLR-related proteins; BBB; blood brain barrier; CSF; cer
Keywords: apo; apolipoprotein; HDL; high-density lipoprotein; HNF-1α,4α; hepatocyte nuclear factor-1α,4α; LRH-1; liver receptor homolog-1; Foxa2; forkhead box A2; PAF; platelet activating factor; LXR; liver X receptor; RXR; retinoid X receptor; FXR; farnesoid X
Keywords: Familial hypercholesterolemia; Diagnostic tools; Functional assay; Mutation pathogenicity; LDLR; APOB; PCSK9; ADH; autosomal dominant hypercholesterolemia; FH; familial hypercholesterolemia; LDLR; LDL receptor; APOB; apolipoprotein B-100; PCSK9; proprotei
Keywords: AD; Alzheimer's disease; BBB; blood-brain barrier; CE; cholesterol esterase; FC; free cholesterol; HMG-CR; 3-hydroxy-3-methylglutaryl-CoA reductase; LXR-α; liver X receptor-α; LDL; low-density lipoprotein; LDLR; low-density lipoprotein receptor; LXR
Keywords: Berberine; Metabolites; LDLR; Lipid accumulation; Human hepatoma cells
Keywords: LD; lipid droplet; LDLR; low-density lipoprotein receptor; NAFLD; non-alcoholic fatty liver disease; FFA; free fatty acids; PLIN; perilipin; PPAR; peroxisome proliferator-activated receptor; SRE; sterol regulatory element; SREBP; sterol regulatory element
Keywords: AMI; acute myocardial infarction; EMT; epithelial-to-mesenchymal transition; APOA1; apolipoprotein A1; LDLR; low density lipoprotein receptor; FGFR1; fibroblast growth factor 1; ACTA2; smooth muscle alpha-actin; EGF; epidermal growth factor; IL1B; IL-1 be
Keywords: AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Keywords: Familial hypercholesterolemia; LDLR; PCSK9; Xanthomas; HRM; Consanguinity;
Keywords: Lipid metabolism; Cholesterol; LDL; PCSK9; FCHL; FCHL; familial combined hyperlipidemia; LDLR; LDL receptor; PCSK9; proprotein convertase subtilisin kexin type 9; SREBP2; sterol regulatory element binding protein 2; LDL-C; LDL cholesterol; HDL-C; HDL chol
Keywords: CYP7A1; cytochrome P450 family 7 subfamily A polypeptide 1; FXRα; farnesoid X receptor α; HMGCR; 3-hydroxy-3-methylglutaryl-CoA reductase; LDLR; low density lipoprotein receptor; PCSK9; proprotein convertase subtilisin/kexin type 9; SREBP2; sterol regul